RaDVaC Mission

The SARS-CoV-2 pandemic has become the greatest global public health crisis in a century. Experts say a vaccine is our best hope for ending the pandemic, but a commercial vaccine won’t arrive until late 2020 or early 2021, if all goes well.

Our mission is rapid development, testing, and public sharing of vaccine research and protocols that are simple enough to be produced and self-administered by individual scientists and qualified healthcare professionals anywhere in the world. We recognize that frontline healthcare workers are uniquely at risk, and it is a top priority to protect those who risk their own safety to protect the health and welfare of all.

Beginning early in the 2020 pandemic, we designed, produced, and self-administered several progressive generations of nasal vaccines against SARS-CoV-2. As of August 2020, over two dozen of us have self-administered the vaccine. We have not filed any patents or other intellectual property protections, and all information on our vaccine designs, material procurement, production, self-administration, and testing are freely shared on this website under open licenses (CC BY 4.0 and OCL-P v1.1) in partnership with the Creative Commons Open COVID Pledge.

In addition to publicly releasing the results of our vaccine work, we are working with other researchers to advance new kinds of testing to assess immunity. We hope to motivate others around the world to build on our efforts, to share their research openly, and to deploy protective vaccines rapidly and safely.

Get in touch

We are eager to share what we’ve learned thus far, and empower anyone interested in advancing the work of providing safe, effective, and accessible vaccines for COVID-19. Contact us here.